Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -16.00 is 238% below its 5-year average of -4.74, near the low end of its 5-year range (-17.85–-1.65).
64.10% below its 12-month average of -9.75.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -4.57.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-16.00
EARNINGS PER SHARE (EPS) AVG TTM
-9.75
EARNINGS PER SHARE (EPS) AVG 3Y
-5.91
EARNINGS PER SHARE (EPS) AVG 5Y
-4.74
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-64.10%
CURRENT VS 3Y AVG
-170.84%
CURRENT VS 5Y AVG
-237.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Bolt Biotherapeutics, Inc.
Market Cap
$6.72M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$6.74M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.76M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.88M
Earnings Per Share (EPS)
-26.72
TTM Avg
-36.23
3Y Avg
-30.51
5Y Avg
-16.78
Market Cap
$6.44M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$7.01M
Earnings Per Share (EPS)
-81.82
TTM Avg
-336.50
3Y Avg
-753.63
5Y Avg
-537.05
Market Cap
$7.03M
Earnings Per Share (EPS)
-7.38
TTM Avg
-1.62
3Y Avg
-0.82
5Y Avg
-0.82
Market Cap
$6.34M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
Market Cap
$7.31M
Earnings Per Share (EPS)
-3.48
TTM Avg
-5.74
3Y Avg
-24.14
5Y Avg
-2936.24
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.72M | -16.00 | -9.75 | -5.91 | -4.74 |
| Aclarion, Inc. (ACON)vs › | $6.74M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -16.46 | -132.36 | -129.45 | -404.68 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -26.72 | -36.23 | -30.51 | -16.78 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | -2.52 | -4.28 | -38.17 | -84.63 |
| KALA BIO, Inc. (KALA)vs › | $7.01M | -81.82 | -336.50 | -753.63 | -537.05 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -7.38 | -1.62 | -0.82 | -0.82 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -1.26 | -1.73 | -1.08 | -0.87 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -3.48 | -5.74 | -24.14 | -2936.24 |
| Femasys Inc. (FEMY)vs › | $6.10M | -4.57 | -13.10 | -16.05 | -14.80 |
Trailing EPS (TTM)
$-16.00
Forward EPS (Est.)
$-17.89
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -17.85 |
| 2024-12-31 | -1.65 |
| 2023-12-31 | -1.83 |
| 2022-12-31 | -2.30 |
| 2021-12-31 | -2.79 |
| 2020-12-31 | -1.99 |
| 2019-12-31 | -3.75 |
| 2018-12-31 | -5.96 |
